| [1] |
Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.
Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study
[J]. Journal of International Oncology, 2024, 51(6): 326-331.
|
| [2] |
Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.
Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer
[J]. Journal of International Oncology, 2024, 51(6): 332-337.
|
| [3] |
Yuan Jian, Huang Yanhua.
Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer
[J]. Journal of International Oncology, 2024, 51(6): 338-343.
|
| [4] |
Fan Zhipeng, Yu Jing, Hu Jing, Liao Zhengkai, Xu Yu, Ouyang Wen, Xie Conghua.
Predictive value of changes in inflammatory markers for prognosis in patients with advanced non-small cell lung cancer treated with the first-line immunotherapy plus chemotherapy
[J]. Journal of International Oncology, 2024, 51(5): 257-266.
|
| [5] |
Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.
Study on the clinical relationship between inflammatory burden index and gastric cancer
[J]. Journal of International Oncology, 2024, 51(5): 274-279.
|
| [6] |
Liu Pingping, He Xuefang, Zhang Yi, Yang Xu, Zhang Shanshan, Ji Yifei.
Risk factors of postoperative recurrence in patients with primary brain glioma and prediction model construction
[J]. Journal of International Oncology, 2024, 51(4): 193-197.
|
| [7] |
Wan Fang, Yang Gang, Li Rui, Wan Qijing.
Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer
[J]. Journal of International Oncology, 2024, 51(4): 204-209.
|
| [8] |
Yao Yixin, Shen Yulin.
Predictive value of serum SOCS3 and TXNIP levels for the prognosis of patients with hepatocellular carcinoma treated with TACE
[J]. Journal of International Oncology, 2024, 51(4): 217-222.
|
| [9] |
Sun Weiwei, Yao Xuemin, Wang Pengjian, Wang Jing, Jia Jinghao.
Exploration of prognostic factors and nomogram construction for advanced non-small cell lung cancer treated with immunotherapy based on hematologic indexes
[J]. Journal of International Oncology, 2024, 51(3): 143-150.
|
| [10] |
Xie Shuping, Sun Yahong, Wang Chao.
Prediction of efficacy of early-stage tumor markers combined with NLR and PLR for immunotherapy in gastric cancer
[J]. Journal of International Oncology, 2024, 51(3): 157-165.
|
| [11] |
Liu Yulan, Jing Haiyan, Sun Jing, Song Wei, Sha Dan.
Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer
[J]. Journal of International Oncology, 2024, 51(3): 175-180.
|
| [12] |
Peng Qin, Cai Yuting, Wang Wei.
Advances on KPNA2 in liver cancer
[J]. Journal of International Oncology, 2024, 51(3): 181-185.
|
| [13] |
Chen Boguang, Wang Sugui, Zhang Yongjie.
Role of serum cholinesterase and inflammatory markers in the prognosis of stage ⅠA -ⅢA breast cancer
[J]. Journal of International Oncology, 2024, 51(2): 73-82.
|
| [14] |
Jin Xudong, Chen Zhongjian, Mao Weimin.
Research progress on the role of MTAP in malignant mesothelioma
[J]. Journal of International Oncology, 2024, 51(2): 99-104.
|
| [15] |
Huang Zhen, Chen Yongshun.
Research progress of circulating tumor DNA in the diagnosis and treatment of hepatocellular carcinoma
[J]. Journal of International Oncology, 2024, 51(1): 59-64.
|
